Lansap in treatment of esophagitis in patients with systemic sclerosis
Objective. To study the efficacy of Lansap (Lansoprasole) in treatment of esophagitis in pts with systemic sclerosis (SS). Methods. 30 SS pts with clinical manifestations and endoscopic signs of esophagitis received lansap 30 or 60 mg/day during two weeks. All pts had a standard endoscopic examinati...
Main Authors: | R T Alekperov, A E Karateev, N G Guseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2003-04-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/901 |
Similar Items
-
Radionuclide Diagnosis of Esophageal Dysmotility and Gastroesophageal Reflux in Patients with Systemic Sclerosis
by: R. A. Bashirov, et al.
Published: (2023-08-01) -
Development of a Diagnostic Model Focusing on Esophageal Dysmotility in Patients with Systemic Sclerosis
by: Peiling Liu, et al.
Published: (2022-12-01) -
Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis
by: Mariko Hara, et al.
Published: (2023-05-01) -
Esophagectomy for esophageal stricture with systemic sclerosis: a case report
by: Yuho Ebata, et al.
Published: (2023-11-01) -
The level of TNF soluble receptor type 1 in patients with systemic sclerosis
by: R Т Alekperov, et al.
Published: (2004-05-01)